Compare Edwards Lifesciences Corporation Common Stock (EW) vs Oklo Inc (OKLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Oklo Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.08 (market cap $48.56B), while Oklo Inc trades at $34.55 (market cap $6.43B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 7.6× Oklo Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| EW | OKLO | |
|---|---|---|
Market Cap | $48.56B | $6.43B |
Volume | 6,520,488 | 16,238,368 |
Sector | Health | Utilities |
52-Week High | $95.18 | $174.14 |
52-Week Low | $72.65 | $34.57 |
Enterprise Value | $45.01B | $3.97B |
Typical Hold Time | — | 32 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OKLO trades at $34.65, down 5.91% today, with a bearish technical signal from moving averages. The company shows no revenue in 2025 and negative net income of -$105.66M, with profitability metrics deeply negative. Analyst consensus remains strongly bullish with a $78.63 price target, but recent news highlights competitive pressures and dilution concerns from stock sales.
The outlook hinges on OKLO's ability to commercialize its nuclear reactor pipeline. High institutional buy ratings suggest long-term potential, but execution risks, cash burn, and intense competition in the SMR space pose significant challenges. The stock offers speculative growth exposure amid substantial operational and financial headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →
